Core Viewpoint - Hillenbrand, Inc. has completed the sale of its majority interest in the Milacron injection molding and extrusion business to Bain Capital for $287 million, aligning with its strategy to enhance margins by focusing on higher growth opportunities [1][4]. Group 1: Sale Details - The Milacron business was acquired by Hillenbrand in 2019 and contributed $526 million in revenues and $64 million in adjusted EBITDA in fiscal 2024 [2][3]. - Following the sale, Bain Capital owns approximately 51% of Milacron and has full operational control, while Hillenbrand retains a 49% stake [4]. Group 2: Financial Implications - Hillenbrand plans to use the net proceeds of approximately $250 million from the sale to repay its debt [4]. - The fiscal 2025 revenue outlook for Hillenbrand's remaining businesses has been updated to a range of $2.625 - $2.790 billion, down from the previous estimate of $2.925 - $3.090 billion [5]. - Total adjusted EBITDA is expected to be between $411 million and $447 million, with adjusted earnings per share anticipated in the range of $2.45 - $2.80 [6]. Group 3: Stock Performance - Hillenbrand's stock has experienced a significant decline, losing 50.5% over the past year, compared to an 11.4% decline in the industry [7].

Brixmor Property Group Inc. (NYSE:BRX) Q4 2024 Earnings Conference Call February 11, 2025 10:00 AM ET Company Participants Stacy Slater - SVP, IR Jim Taylor - CEO Brian Finnegan - President and COO Steve Gallagher - EVP and CFO Conference Call Participants Samir Khanal - Evercore ISI Andrew Reale - Bank of America Greg McGinniss - Scotiabank Craig Mailman - Citi Dori Kesten - Wells Fargo Juan Sanabria - BMO Capital Markets Connor Mitchell - Piper Sandler Caitlin Burrows - Goldman Sachs Linda Tsai - Jefferie ...